<?xml version="1.0" encoding="UTF-8"?>
<root>
    <author>ENA</author>
    <category>State</category>
    <date>2025-04-28 16:56:25</date>
    <fulldesc>&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;strong&gt;Ahmedabad, Apr 28 (KNN) &lt;/strong&gt;Gujarat has reinforced its status as India's pharmaceutical leader by approving 183 new allopathic drug manufacturing facilities in the fiscal year 2024 25, the highest number since the COVID-19 pandemic. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;This surge brings the total number of new allopathic drug plants approved since March 2019 to over 800, underscoring the state's pivotal role in the nation's pharmaceutical landscape. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;H.G. Koshia, Commissioner of the Gujarat Food and Drug Control Administration (FDCA), highlighted that these new plants are poised to become operational soon, further bolstering Gujarat's dominance in the sector. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The average investment per plant is estimated at Rs 50 crore, with some companies investing significantly more, leading to a projected total investment of approximately Rs 12,000 crore for the fiscal year. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Industry experts attribute this growth to Gujarat's mature pharmaceutical ecosystem, which includes robust infrastructure, skilled workforce, and favourable policies. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Additionally, many pharmaceutical units from northern India are relocating to Gujarat, drawn by its conducive business environment. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Gujarat's pharmaceutical industry already contributes 30% of India's pharmaceutical production and 28% of its total pharma exports. The state houses over 4,000 manufacturing units, providing employment to about 50,000 individuals. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;It also accounts for 53% of India's medical devices manufacturing and 78% of the country's cardiac stents manufacturing. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;The state's commitment to fostering pharmaceutical growth is evident through initiatives like the Vibrant Gujarat Global Investor Summit, which aims to attract further investments and solidify Gujarat's position as a global pharmaceutical hub. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;With these developments, Gujarat continues to pave the way for India's pharmaceutical advancements, reinforcing its moniker as the  Pharmacy of the Nation. &lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;&lt;span style=&quot;font-size:14px&quot;&gt;(KNN Bureau)&lt;/span&gt;&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&#13;
</fulldesc>
    <id>41896</id>
    <link>https://knnindia.co.in/news/newsdetails/state/183-new-pharma-units-set-up-in-gujarat-with-investment-of-rs-12000-crore-in-2024-25</link>
    <pubDate>2025-04-28 16:56:25</pubDate>
    <source>knnindia.co.in</source>
    <title>183 New Pharma Units Set-up In Gujarat With Investment of Rs 12,000 crore in 2024-25</title>
</root>
